BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37598790)

  • 1. The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines.
    Braet H; Andretto V; Mariën R; Yücesan B; van der Vegte S; Haegebaert R; Lollo G; De Smedt SC; Remaut K
    Acta Biomater; 2023 Oct; 170():318-329. PubMed ID: 37598790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
    Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
    Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
    Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intraperitoneal delivery of charged, aerosolized curcumin nanoparticles by electrostatic precipitation.
    Castagna A; Zander AJ; Sautkin I; Schneider M; Shegokar R; Königsrainer A; Reymond MA
    Nanomedicine (Lond); 2021 Jan; 16(2):109-120. PubMed ID: 33448879
    [No Abstract]   [Full Text] [Related]  

  • 5. CO
    Braet H; Fransen PP; Mariën R; Lollo G; Ceelen W; Vervaet C; Balcaen L; Vanhaecke F; Vanhove C; van der Vegte S; Gasthuys E; Vermeulen A; Dankers PYW; De Smedt SC; Remaut K
    ACS Appl Mater Interfaces; 2023 Oct; 15(42):49022-49034. PubMed ID: 37819736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
    BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer.
    Shariati M; Lollo G; Matha K; Descamps B; Vanhove C; Van de Sande L; Willaert W; Balcaen L; Vanhaecke F; Benoit JP; Ceelen W; De Smedt SC; Remaut K
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):29024-29036. PubMed ID: 32506916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic Intraperitoneal Aerosol Delivery of Nanoparticles: Proof of Concept and Preclinical Validation.
    Van de Sande L; Rahimi-Gorji M; Giordano S; Davoli E; Matteo C; Detlefsen S; D'Herde K; Braet H; Shariati M; Remaut K; Xie F; Debbaut C; Ghorbaniasl G; Cosyns S; Willaert W; Ceelen W
    Adv Healthc Mater; 2020 Aug; 9(16):e2000655. PubMed ID: 32548967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application.
    Reymond M; Demtroeder C; Solass W; Winnekendonk G; Tempfer C
    Pleura Peritoneum; 2016 Jun; 1(2):109-116. PubMed ID: 30911614
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery.
    Braet H; Rahimi-Gorji M; Debbaut C; Ghorbaniasl G; Van Walleghem T; Cornelis S; Cosyns S; Vervaet C; Willaert W; Ceelen W; De Smedt SC; Remaut K
    Eur J Pharm Biopharm; 2021 Dec; 169():134-143. PubMed ID: 34634467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook.
    Rahimi-Gorji M; Van de Sande L; Debbaut C; Ghorbaniasl G; Braet H; Cosyns S; Remaut K; Willaert W; Ceelen W
    Adv Drug Deliv Rev; 2020; 160():105-114. PubMed ID: 33132169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.
    Khosrawipour V; Khosrawipour T; Falkenstein TA; Diaz-Carballo D; Förster E; Osma A; Adamietz IA; Zieren J; Fakhrian K
    Anticancer Res; 2016 Sep; 36(9):4595-600. PubMed ID: 27630300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes.
    Shariati M; Zhang H; Van de Sande L; Descamps B; Vanhove C; Willaert W; Ceelen W; De Smedt SC; Remaut K
    Pharm Res; 2019 Jun; 36(9):126. PubMed ID: 31236829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
    Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
    Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ideal Nozzle Position During Pressurized Intraperitoneal Aerosol Chemotherapy in an
    Piao J; Park SJ; Lee H; Kim J; Park S; Lee N; Kim SI; Lee M; Song G; Lee JC; Kim HS;
    Anticancer Res; 2021 Nov; 41(11):5489-5498. PubMed ID: 34732419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
    Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
    BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
    Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
    Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC)
    Khosrawipour V; Mikolajczyk A; Schubert J; Khosrawipour T
    Anticancer Res; 2018 Jun; 38(6):3447-3452. PubMed ID: 29848695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
    Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
    Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.